FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37699350> ?p ?o ?g. }

• Q37699350 description "2010 ആഗസ്റ്റ് 1നു പ്രസിദ്ധീകരിച്ച ശാസ്ത്രീയ ലേഖനം" @default.
• Q37699350 description "article científic" @default.
• Q37699350 description "article scientifique" @default.
• Q37699350 description "articolo scientifico" @default.
• Q37699350 description "artigo científico" @default.
• Q37699350 description "artículu científicu espublizáu en 2010" @default.
• Q37699350 description "bilimsel makale" @default.
• Q37699350 description "scientific article published on August 2010" @default.
• Q37699350 description "vedecký článok" @default.
• Q37699350 description "vetenskaplig artikel" @default.
• Q37699350 description "videnskabelig artikel" @default.
• Q37699350 description "vědecký článek" @default.
• Q37699350 description "wetenschappelijk artikel" @default.
• Q37699350 description "wissenschaftlicher Artikel" @default.
• Q37699350 description "наукова стаття, опублікована в серпні 2010" @default.
• Q37699350 description "научни чланак" @default.
• Q37699350 description "مقالة علمية نشرت في أغسطس 2010" @default.
• Q37699350 name "Recent approaches to the development of antigen-specific immunotherapies for myasthenia gravis." @default.
• Q37699350 name "Recent approaches to the development of antigen-specific immunotherapies for myasthenia gravis." @default.
• Q37699350 name "Recent approaches to the development of antigen-specific immunotherapies for myasthenia gravis." @default.
• Q37699350 type Item @default.
• Q37699350 label "Recent approaches to the development of antigen-specific immunotherapies for myasthenia gravis." @default.
• Q37699350 label "Recent approaches to the development of antigen-specific immunotherapies for myasthenia gravis." @default.
• Q37699350 label "Recent approaches to the development of antigen-specific immunotherapies for myasthenia gravis." @default.
• Q37699350 prefLabel "Recent approaches to the development of antigen-specific immunotherapies for myasthenia gravis." @default.
• Q37699350 prefLabel "Recent approaches to the development of antigen-specific immunotherapies for myasthenia gravis." @default.
• Q37699350 prefLabel "Recent approaches to the development of antigen-specific immunotherapies for myasthenia gravis." @default.
• Q37699350 P1433 Q37699350-220630D7-DFC4-48C0-8CB8-20FD8397B5E7 @default.
• Q37699350 P1476 Q37699350-45A8157B-AB99-4F09-BE59-BAD17DF2154B @default.
• Q37699350 P2093 Q37699350-1D2A8066-A360-42EF-9C97-6ADD2605D1DA @default.
• Q37699350 P2093 Q37699350-E021F6AD-EA8C-4B78-BD7E-647E552E3E89 @default.
• Q37699350 P2093 Q37699350-F9EDBAD2-7503-46EB-B412-E8AA76B8FD4A @default.
• Q37699350 P2093 Q37699350-FDA60596-2138-4804-AAB3-79AB83275989 @default.
• Q37699350 P2860 Q37699350-07D055E0-CCC5-48AF-A3FB-AC0F175ACC67 @default.
• Q37699350 P2860 Q37699350-11E9E621-8BD7-4614-99E3-F64C4A3F90B5 @default.
• Q37699350 P2860 Q37699350-157AC773-F046-41FB-A51C-DB54992A52C1 @default.
• Q37699350 P2860 Q37699350-161AC229-85FC-48CA-A473-FB33990162DA @default.
• Q37699350 P2860 Q37699350-2D8F0650-517D-4604-92A7-232D1D260A7C @default.
• Q37699350 P2860 Q37699350-30E10C68-4AC8-4EE1-9F9D-B3C7498E0DE2 @default.
• Q37699350 P2860 Q37699350-326BC972-3B7B-4BF3-AE8A-59FC278FF106 @default.
• Q37699350 P2860 Q37699350-3272B579-FE46-4E15-8D79-48785652C705 @default.
• Q37699350 P2860 Q37699350-33C78204-2066-4DE0-83FA-F4C3E09F7874 @default.
• Q37699350 P2860 Q37699350-3D7F4122-99C9-4233-BD84-22BAD4475F39 @default.
• Q37699350 P2860 Q37699350-45A5221A-6993-42C3-8FB7-1EA6DEDBA454 @default.
• Q37699350 P2860 Q37699350-4D4EBE34-FEAF-4292-B221-58C651847C5B @default.
• Q37699350 P2860 Q37699350-56A15634-1CB8-43F4-80C3-1EE5A51821B5 @default.
• Q37699350 P2860 Q37699350-57FA0EB5-FE2A-491B-B5E2-FC38141D400E @default.
• Q37699350 P2860 Q37699350-5A58DA46-1F46-4869-B80C-DC35C2119584 @default.
• Q37699350 P2860 Q37699350-5E25E655-4A28-471F-BBC1-49F071BC082A @default.
• Q37699350 P2860 Q37699350-5E482567-DD2D-42DD-9636-DE0E32423949 @default.
• Q37699350 P2860 Q37699350-62FF7A5A-C772-445A-917F-222744E4B214 @default.
• Q37699350 P2860 Q37699350-67480A1F-0179-4976-817A-FA00A4664078 @default.
• Q37699350 P2860 Q37699350-67BDE911-71A4-4687-B41E-7E3EB77AAA34 @default.
• Q37699350 P2860 Q37699350-67C5C958-DCD2-4EAB-B5CD-3ADF509AA053 @default.
• Q37699350 P2860 Q37699350-6E50536F-A1AF-42ED-A1CE-4F2A01965371 @default.
• Q37699350 P2860 Q37699350-73172FD7-C969-4763-9139-348E0D12DA4C @default.
• Q37699350 P2860 Q37699350-737900D9-64F9-413F-A5C3-1E9B82FC57F0 @default.
• Q37699350 P2860 Q37699350-7435B78B-CB46-42D9-AD9D-8792E6CF39F0 @default.
• Q37699350 P2860 Q37699350-79E58DDA-670C-4BCF-9C21-AD597BF4EFE1 @default.
• Q37699350 P2860 Q37699350-7F36EA2A-F86C-492A-AA82-7B6BFAACB8C3 @default.
• Q37699350 P2860 Q37699350-8714CEC3-F9B3-4FB1-AF05-D33EB67FC499 @default.
• Q37699350 P2860 Q37699350-8B922A01-8235-419A-8BC3-E62FD6BC8032 @default.
• Q37699350 P2860 Q37699350-9376EA9F-612C-488C-BCAA-7B8A21A016ED @default.
• Q37699350 P2860 Q37699350-9C553595-775C-4A70-BB94-B544A6C9ED8F @default.
• Q37699350 P2860 Q37699350-A5B303DE-CD39-4DFB-9774-82F282DF7F9D @default.
• Q37699350 P2860 Q37699350-AA95688D-B9FD-4878-A053-C16B45ED07AF @default.
• Q37699350 P2860 Q37699350-B813A0C5-08EF-489B-809D-2267DE546D8B @default.
• Q37699350 P2860 Q37699350-BA07815D-164C-4FED-BC4D-612FBBAC9A43 @default.
• Q37699350 P2860 Q37699350-BED8C94C-A3B8-4CEE-AEC0-9208D71F15C7 @default.
• Q37699350 P2860 Q37699350-D0517A53-CAFD-4064-905B-50F2183D48C8 @default.
• Q37699350 P2860 Q37699350-D90F60AE-04C6-4916-B0EC-B18BA7B65197 @default.
• Q37699350 P2860 Q37699350-DC537CAF-B07A-4920-B502-7836D1F20AB9 @default.
• Q37699350 P2860 Q37699350-DD7E2C23-6C65-48DF-AE6F-1E33649B0E14 @default.
• Q37699350 P2860 Q37699350-E2BD9834-08A2-49C4-A6ED-826315CC0FA4 @default.
• Q37699350 P2860 Q37699350-E37D7646-FBA2-4865-8F68-648EA623FEB0 @default.
• Q37699350 P2860 Q37699350-EB833505-5329-4A63-91E1-98154D87B613 @default.
• Q37699350 P2860 Q37699350-FFE6FCAA-5359-4C36-B184-E2D5111F77CB @default.
• Q37699350 P304 Q37699350-A05EB5B1-E61E-497C-BA6E-485CEA563BDC @default.
• Q37699350 P31 Q37699350-289ba24e-3cfa-4d5b-8229-5919f93596ed @default.
• Q37699350 P31 Q37699350-8B698EA6-EC23-470E-BA8C-C318F779E3C8 @default.
• Q37699350 P356 Q37699350-D19B4E34-F410-4DBA-A38C-EC75AE1EEAB3 @default.
• Q37699350 P433 Q37699350-7660F981-70B1-4550-A453-19AE14FA2984 @default.
• Q37699350 P478 Q37699350-B7EB6004-E525-43BD-9C83-4AFD93B1AAC9 @default.
• Q37699350 P50 Q37699350-086E97D2-A449-4DE5-88AE-1AE3EBCCCA06 @default.
• Q37699350 P50 Q37699350-529C5CBB-7096-45FA-809F-F57A17EE96F7 @default.
• Q37699350 P577 Q37699350-7E04B233-8E61-47FB-A914-AA2B289367E4 @default.
• Q37699350 P5875 Q37699350-82571394-2068-4FEB-8687-549CC3B3DC72 @default.
• Q37699350 P698 Q37699350-0941CC92-862C-4AB8-8BFA-DCF7DBB8935D @default.
• Q37699350 P921 Q37699350-388B2F9A-D434-4E79-81D7-8CD2CD653FCB @default.
• Q37699350 P921 Q37699350-3EC15A40-953A-4971-98EA-58062B5B75BA @default.
• Q37699350 P356 08916930903518099 @default.
• Q37699350 P698 20187712 @default.
• Q37699350 P1433 Q4826348 @default.
• Q37699350 P1476 "Recent approaches to the development of antigen-specific immunotherapies for myasthenia gravis" @default.
• Q37699350 P2093 "George Lagoumintzis" @default.
• Q37699350 P2093 "Gregory Kordas" @default.
• Q37699350 P2093 "Konstantinos Lazaridis" @default.
• Q37699350 P2093 "Socrates J Tzartos" @default.
• Q37699350 P2860 Q27631812 @default.
• Q37699350 P2860 Q28202947 @default.

• next